Martin Hutchings
0000-0003-3873-1741
Rigshospitalet
4 papers found
Refreshing results…
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
An Epidemiological Model to Estimate the Prevalence of Diffuse Large B-Cell Lymphoma in the United States
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
Missing publications? Search for publications with a matching author name.